BioSpace News Archive

Adaptimmune announced several changes to its executive leadership team. Perhaps the biggest news is that Rafael Amado, president of R&D, is leaving the company “to pursue other opportunities.”

The researchers, led by Hans-Peter Kiem, used CRISPR to modify hematopoietic stem cells from nonhuman primates. They then introduced a naturally occurring mutation that increases the amount of fetal hemoglobin.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

There were a number of major companies reporting their second-quarter financials for the year. Here’s a look at five of the bigger announcements this week.

Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce the receipt of firm commitments in respect of a A$40m placement led by specialist US-based biotech investment funds and leading US institutional investors, as well as the appointment of two new experienced dermatology executives.

Singapore scientists and clinicians have discovered a promising use of antibodies to target a new cancer antigen, as an alternative for chemotherapy

The Journal of Medical Device Regulation’s recently redesigned website – www.GlobalRegulatoryPress.com – reflects the Journal’s emphasis on complete customer satisfaction.

Cristal Therapeutics announces that Dr Werner Cautreels is joining the Company’s supervisory board taking on the role of Chairman.

Dr John Prendergast will showcase the potential of New Synthetic Antibiotics

Clinically advanced vaccine, ACI-35.030, designed to reduce and to prevent the spread and development of Tau pathology